$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > Trop-2

乳腺癌|乳腺癌特药

总生存期接近翻倍!Trop-2抗体偶联药物Trodelvy显著降低三阴性乳腺

戈沙妥珠单抗|最新研究

瞭望FM丨王殊教授:靶向TROP-2,戈沙妥珠单抗全面开启三阴性乳腺癌精
总生存期接近翻倍!Trop-2抗体偶联药物Trodelvy显著降低三阴性乳腺

戈沙妥珠单抗|上市信息

拓达维(Trodelvy)在中国获批用于转移性三阴性乳腺癌的二线治疗
全球首款靶向TROP-2的ADC药物Trodelvy获FDA批准上市,治疗三阴性乳

|